Is Gem-Doce an alternative to BCG treatment for people with early bladder cancer?

You might be able to take part in this study if you are 18 years or older and have recently been diagnosed with a type of early bladder cancer that is usually treated with BCG. This mostly includes bladder cancer that hasn't spread into the muscle wall of the bladder and is considered 'high-risk', such as certain types of T1, Ta, or CIS bladder cancer. You would also need to have had any cancerous growths completely removed from your bladder, and be prepared to use effective birth control if needed.

There are also some reasons why you wouldn't be able to join. For example, if you've had bladder cancer before, or if your cancer is a very rare type of bladder cancer. You also can't take part if you have certain other medical conditions or are taking specific medications that might interfere with the treatments. If you are pregnant or breastfeeding, or have certain active infections like HIV or Hepatitis, you wouldn't be eligible. Your doctor will carefully check all these details to see if the study is right for you.

If you decide to join the study, you'll be randomly assigned to receive one of two treatments: either the usual BCG treatment or the new Gem-Doce treatment. Both treatments are given directly into your bladder during hospital visits. You'll receive these treatments over two years. Following this, you will have regular check-ups for a total of five years, just as you would if you weren't in the study. You might also be asked to complete some optional questionnaires about your quality of life and how often you use healthcare. These questions are about how you're feeling and how the treatment affects your daily life. There will also be a short, optional and confidential survey about your general background information.